Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,003
Closed -$259K 62
2022
Q3
$259K Sell
3,003
-1,386
-32% -$124K 0.27% 72
2022
Q2
$400K Sell
4,389
-171
-4% -$15.2K 0.4% 47
2022
Q1
$374K Buy
+4,560
New +$360K 0.13% 74
2020
Q1
Sell
-2,462
Closed -$214K 62
2019
Q4
$214K Buy
+2,462
New +$202K 0.1% 75
2015
Q3
Sell
-67,072
Closed -$3.64M 78
2015
Q2
$3.64M Hold
67,072
1.9% 14
2015
Q1
$3.68M Hold
67,072
1.95% 17
2014
Q4
$3.63M Hold
67,072
2.11% 15
2014
Q3
$3.79M Hold
67,072
1.91% 19
2014
Q2
$3.7M Hold
67,072
1.99% 16
2014
Q1
$3.63M Hold
67,072
1.79% 20
2013
Q4
$3.2M Hold
67,072
1.56% 23
2013
Q3
$3.05M Hold
67,072
1.94% 18
2013
Q2
$2.97M Buy
+67,072
New +$3M 1.97% 16

Other funds holding MRK

DSC Advisors's MRK Position: Q4 2022 in Review

DSC Advisors sold out of Merck (MRK) in Q4 2022, closing a stake of 3,003 shares — an estimated $259K sold.

DSC Advisors first reported a position in MRK in Q2 2013 and held it in 13 quarters. The position peaked at $3.79M in Q3 2014. 3,234 funds tracked by Wall St. Rank hold MRK as of Q4 2022.

  • DSC Advisors reported no remaining Merck position as of Q4 2022 after selling out during the quarter.
  • DSC Advisors sold 3,003 Merck shares in Q4 2022, an estimated $259K.
  • DSC Advisors first reported a position in Merck in Q2 2013 and held it in 13 quarters.
  • DSC Advisors's Merck position peaked at $3.79M in Q3 2014.
  • 3,234 funds tracked by Wall St. Rank held Merck as of Q4 2022.

Based on DSC Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.